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Background: Mucosal infections are a major global health problem and it is generally accepted that mucosal
vaccination strategies, able to block infection at their entry site, would be preferable with respect to other
prevention approaches. However, there are still relatively few mucosal vaccines available, mainly because of the lack
of efficient delivery systems and of mucosal adjuvants. Recombinant bacterial spores displaying a heterologous
antigen have been shown to induce protective immune responses and, therefore, proposed as a mucosal delivery
system. A non-recombinant approach has been recently developed and tested to display antigens and enzymes.
Results: We report that the binding subunit of the heat-labile toxin (LTB) of Escherichia coli efficiently adsorbed on
the surface of Bacillus subtilis spores. When nasally administered to groups of mice, spore-adsorbed LTB was able to
induce a specific immune response with the production of serum IgG, fecal sIgA and of IFN-γ in spleen and
mesenteric lymph nodes (MLN) of the immunized animals. Dot blotting experiments showed that the non-recombinant
approach was more efficient than the recombinant system in displaying LTB and that the efficiency of display could be
further increased by using mutant spores with an altered surface. In addition, immunofluorescence microscopy
experiments showed that only when displayed on the spore surface by the non-recombinant approach LTB was found in
its native, pentameric form.
Conclusion: Our results indicate that non-recombinant spores displaying LTB pentamers can be administered by the
nasal route to induce a Th1-biased, specific immune response. Mutant spores with an altered coat are more efficient than
wild type spores in adsorbing the antigen, allowing the use of a reduced number of spores in immunization procedures.
Efficiency of display, ability to display the native form of the antigen and to induce a specific immune response propose
this non-recombinant delivery system as a powerful mucosal vaccine delivery approach.Background
Several vaccination strategies based on the development
of microbial and viral systems to deliver molecules with
antigenic properties have been proposed and recently
reviewed [1-4]. In this context, bacterial endospores have
also been considered to display heterologous antigens on
their surface [5,6]. Endospores are produced by Gram-
positive microorganisms mainly belonging to the Bacil-
lus and Clostridium genera and including more than
1,000 species [6]. The endospore (spore), a quiescent cel-
lular type produced in response to harsh environments,* Correspondence: ericca@unina.it
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reproduction in any medium, provided the orcan survive in its dormant state for long periods, resist-
ing to a vast range of stresses such as high temperature,
dehydration, absence of nutrients and presence of toxic
chemicals. When the environmental conditions amelior-
ate, the spore germinates originating a vegetative cell
able to grow and sporulate [7]. The ability of the spore
to survive non-physiological conditions is, in part, due
to its surface structures: the coat, formed by at least sev-
enty different proteins (Cot proteins) organized in an
inner and an outer part [7] and the crust, a recently dis-
covered outermost layer of the spore [8].
A number of reasons support the use of the spore as a
vaccine delivery system. The remarkable and well docu-
mented resistance of spores to various environmentalLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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system. Proteins to be displayed on the spore are produced
in the mother cell compartment of the sporangium and
are assembled around the forming spore without the need
to be translocated across a membrane, thus eliminating
the size constrains of cell-based display systems [5,6,9].
The safety record of several endospore-forming species
[10], makes spores of those species ideal candidates as ve-
hicles to deliver molecules to mucosal surfaces.
The strategy to obtain the spore surface display of heter-
ologous proteins is based on the construction of gene fu-
sions between the gene coding for a selected spore surface
protein (carrier) and the heterologous DNA coding for the
protein to be displayed [5]. By this approach a variety of
heterologous proteins have been displayed and recombinant
spores proposed as vaccine vehicles [11-13], as biocatalysts
[9], or as a bioremediation tool [14]. This strategy, based on
the genetic engineering of the host, produces recombinant
organisms to be used as a live biotechnological tool.
The release of live recombinant organisms into nature
raises concerns over the use and clearance of genetically
modified microorganisms and is a major drawback of all
microbe-based display systems [15]. To overcome this
obstacle, a non-recombinant approach to use spores as a
display system has been recently proposed and model
proteins efficiently exposed. The mammalian NADPH-
cytochrome P450 reductase [16], the Escherichia coli
phytase [17], the beta-galactosidase of Alicyclobaccilus
acidocaldaricus [18] and a collections of antigens (TTFC
of Clostridium tetani, PA of Bacillus anthracis, Cpa of
Clostridium perfringens and glutathione S transferase of
Shistosomas japonica) [19] were all adsorbed to spores
and shown to either retain their specific activity [16-18] or
induce specific and protective immune responses in muco-
sally immunised mice [19]. Spore adsorption resulted to be
more efficient when the pH of the binding buffer was
acidic (pH 4) and less efficient or totally inhibited at pH
values of 7 or 10 [18,19]. A combination of electrostatic
and hydrophobic interactions between spores and antigens
were suggested to drive the adsorption, that was shown to
be not dependent on specific spore coat components but
rather on the negatively charged and hydrophobic surface
of the spore [19]. However, at least in the case of the beta-
galactosidase of A. acidocaldaricus, the electrostatic forces
were not found essential in the adsorption to the spore sur-
face [18]. The same study also showed that the interaction
with the spore protected the enzyme from exposure to
conditions of acidic pH and high temperatures and that
mutants with severely altered spore surface interacted
more efficiently than isogenic wild type spores with the
beta-galactosidase [18].
In the present work we used a well-characterized anti-
gen, the binding subunit of the heat-labile toxin (LTB) of
E. coli [20] to study spore adsorption. Since LTB hasbeen previously displayed on the spore surface by the re-
combinant approach [11] it was possible to compare the
efficiency of display of the two approaches. Here we first
show that LTB can be adsorbed to B. subtilis spores and
that the adsorbed antigen induces a specific immune re-
sponse in mucosally immunized mice. Then, we show
that LTB is displayed more efficiently by the non-
recombinant than by the recombinant approach and that
mutant spores are more efficient than isogenic wild type
spores. Finally, we show that only by the non-
recombinant approach LTB is displayed in its active
pentameric form.
Results and discussion
LTB of E. coli adsorbs to B. subtilis spores
Aliquots (2.0 μg) of LTB, over-expressed in E. coli and
purified by affinity chromatography columns (Methods),
were incubated in 200 μl of PBS buffer with 2.0 × 109
spores of the B. subtilis strain PY79 [21], purified by
renographin gradient [22]. After one hour of incubation
at 25°C spores were collected by centrifugation and sur-
face proteins extracted by SDS-DTT treatment [18].
Proteins were then analyzed by western blot with anti-
LTB antibody [11] and LTB was found among the pro-
teins extracted from the spore surface (Figure 1A). As
previously reported for other antigens [19] and an en-
zyme [18], the adsorption was more efficient when the
binding reaction was performed at pH 4.0 than at pH
7.0 and was almost abolished at pH 10.0 (Figure 1A).
In order to assess the amount of LTB adsorbed on the
spore surface, we fractionated by centrifugation the adsorp-
tion reaction mixture obtaining a pellet with the spores
and LTB bound to them and a supernatant with unbound,
free LTB. Both fractions were analyzed by dot blot with
anti-LTB antibody (Figure 1B) and the intensity of the vari-
ous spots quantified by a densitometric analysis. In our ex-
perimental conditions (pH 4.0, 2.0 × 109 spores and 2.0 μg
of purified LTB in 200 μl) about 2% of LTB was left free in
the supernatant (Table 1) while about 80% of it was de-
tected in the pellet fraction (Table 2) and therefore bound
to spore. The remaining 18% of LTB used in the adsorption
reaction was either lost in the washing steps of the dot blot
experiment or degraded.
Spore-adsorbed LTB induces a specific immune response
in nasally immunized mice
In a previous study, the gene coding for LTB was fused
to the gene coding for the spore coat protein CotC and
the recombinant strain of B. subtilis shown to display an
average of 9.6 × 10-5 pg of CotC-LTB per spore [11].
Nine doses of 1.0 × 1010 recombinant spores (corre-
sponding to 0.55 μg of LTB/dose for a total of 4.95 μg of
LTB) were used to mucosally immunize groups of mice
and the LTB-specific immune response monitored [11].
Figure 1 Visualization of spore adsorption by western and dot blotting experiments. (A) Upon adsorption with purified LTB at various pH
conditions, spore surface proteins were extracted by SDS-DTT treatment, fractionated on SDS-PAGE and analyzed by western blot. (B) The
adsorption mixture (200 μl) was fractionated by centrifugation and different amounts of pellet (spores) and supernatant (free LTB) fractions were
analyzed by dot blot. Serial dilutions of purified LTB were used as a standard. Immuno-reactions in A and B were performed with anti-LTB
antibody [11] and anti-rabbit secondary antibody conjugated with the horseradish peroxidase.
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specific serum IgG and fecal sIgA was observed [11]. To
analyze whether spore-adsorbed LTB molecules were also
able to induce an immune response, groups of mice were
nasally immunized with purified LTB (2.0 μg/dose), spores
alone (2.0 × 109/dose) or spore-adsorbed LTB (2.0 × 109
spores adsorbed with 2.0 μg of LTB/dose). Animals were
dosed once a week for 8 weeks and were sacrificed for
analysis one week after the last dose. As calculated in the
previous paragraph, 2.0 × 109 spores adsorbed with 2.0 μg
of LTB displayed about 1.6 μg of LTB (80% of the total
LTB), therefore, eight doses of spores carried 12.8 μg of
LTB, about 2.5-fold more than that delivered by the re-
combinant approach but using a 5-fold lower number of
spores (2.0 × 109 instead of 1.0 × 1010 per dose). A statisti-
cally higher production of fecal sIgA, indicative of aTable 1 Densitometric analysis of dot blot experiments
with the supernatants of the adsorption reaction with
wild type spores






Amount of LTB μg
in 200 μl (% total)
Purified LTB 12.50 ng 20.125 NA NA
6.25 ng 8.753 NA NA
3.12 ng 3.696 NA NA
Free LTB 40 μl 13.211 8.8 0.04 (2.2)
20 μl 6.689 3.9 0.03 (1.9)
10 μl 3.507 2.2 0.04 (2.2)mucosal immune response, was observed in mice immu-
nized with spore-adsorbed LTB than in mice immunized
with spores alone (negative control), whereas purified
LTB was unable to induce sIgA at the tested dose (Fig-
ure 2A). The analysis of serum antibodies showed that
both anti-LTB IgA (Figure 2B) and IgG (Figure 2C) titers
were significantly increased following administration of
spore adsorbed LTB in comparison to antigen alone. We
speculate that the ability of nasally administered spore-
adsorbed LTB to induce a stronger immune response than
purified LTB could be related to an increased antigen up-
take by immune competent cells or, alternatively, to a re-
duced antigen degradation, as previously shown for the
beta-galactosidase of A. acidocaldaricus [18]. Further ex-
periments are required to fully address this issue.Table 2 Densitometric analysis of dot blot experiments










Amount of LTB (μg/
2.0 × 109 spore)
(% total)
Purified LTB 25.00 ng 12.259 NA NA
12.50 ng 6.689 NA NA
6.25 ng 3.507 NA NA
Bound LTB 1.0 × 107 5.219 9.6 1.92 (96)
5.0 × 106 2.756 4.3 1.72 (86)
2.5 × 106 1.450 1.5 1.20 (60)
Figure 2 Antibody production in mice immunized with spore-adsorbed LTB. BALB/c mice were treated with antigen alone (n=4) (LTB),
spores alone (n=10) (spores) or LTB-adsorbed spores (n=12) (spores-LTB). (A) Anti-LTB IgA detected in fecal pellet at the end of treatment;
absorbance values are shown. Anti-LTB IgA (B) and IgG (C) levels detected in mice serum; reciprocal endpoint titers are shown. Bars represent
median values. Results are representative of two independent experiments. *, P < 0.05; **, P < 0.01, ***, P < 0.001.
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then examined. The analysis of IgG subclasses did not
show a preferential increase of IgG1 or IgG2a subtypes
(Figure 3AB). Spleen and mesenteric lymph nodes (MLN)
of immunized animals were analyzed for LTB-specific pro-
duction of IL-4 and interferon-γ (IFN-γ). While IL-4 was
not produced at detectable levels (not shown), IFN-γ wasFigure 3 Characterization of the immune response. A Th1-like immunit
adsorbed spores. Anti-LTB IgG1 (A) and IgG2a (B) levels detected in mice;
secreted in vitro from spleen (C) and MLN cells (D); data are reported after
stimulation. Bars represent median values. Results are representative of twoproduced by both spleen and MLN cells of mice immu-
nized with spore-adsorbed LTB at levels statistically higher
than by those immunized with purified LTB (Figure 3CD).
Although a comparison between our data and those previ-
ously obtained with recombinant spores displaying LTB
[11] is not possible for the different immunization route
(oral vs. nasal) and the different amounts of antigeny was induced in BALB/c mice following administration of LTB-
reciprocal endpoint titers are shown. Antigen-specific IFN-γ levels
subtracting the cytokine values detected in the absence of antigen
independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Figure 4 Efficiency of LTB adsorption on wild type and mutant
spores. Upon adsorption with 2.0 μg of purified LTB the reaction
mixture was fractionated by centrifugation. Supernatant (A) and
pellet (B) fractions were serially diluted and analyzed by dot blot.
Serial dilutions of purified LTB were used as a standard. Immuno-
reactions in A and B were performed with anti-LTB antibody [11]
and anti-rabbit secondary antibody conjugated with the
horseradish peroxidase.
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viously reported humoral response. Moreover, the statisti-
cally significant production of IFN-γ and the lack of
detectable levels of LTB-specific IL-4 of immunized animals
suggest that the nasal administration of spore-adsorbed
LTB promotes a significant cellular (Th1-biased) immune
response in both systemic and mucosal compartments. In-
duction of a Th-1 type of immune response by antigens car-
ried by spores is in agreement with previous observations
deriving from experiments with spores displaying different
antigens [19,23].
Increased efficiency of LTB display
The non-recombinant display system was more efficient
than the recombinant approach and allowed the delivery
of a high amount of antigen with a low number of spores.
To verify whether it was possible to further increase the
amount of LTB adsorbed to spores we tested a collection
of mutants of B. subtilis with an altered spore surface. In
agreement with previous data obtained with various anti-
gens [19] and an enzyme [18], LTB adsorption was similar
in wild type spores (PY79) and in isogenic null mutants
lacking cotA, cotB, cotC, cotD or cotG (not shown). How-
ever, it has also been reported that the spore adsorption of
the beta-galactosidase of A. acidocaldaricus was signifi-
cantly increased in cotH null mutant spores that have a
strongly altered coat [18]. We then analyzed the adsorp-
tion of LTB to cotHmutant spores. After one hour of incu-
bation at 25°C we fractionated by centrifugation the
adsorption reaction as described above, and performed dot
blot experiments with anti-LTB antibody on both super-
natant (free LTB) and pellet (spore-bound LTB) fractions
(Figure 4). A densitometric analysis of the various spots in-
dicated that the amount of LTB not bound to spores was
much lower in the mutant than in the isogenic wild type
strain (Figure 4A and Table 3), while spore-bound LTB
was much higher in the mutant than in the wild type
(Figure 4B and Table 4). Therefore, results of Figure 4 and
Tables 3 and 4 indicate that mutant spores with a strongly
altered surface are more efficient than wild type spores in
adsorbing LTB and confirm previous data on the adsorp-
tion of the beta-galactosidase of A. acidocaldaricus [18].
Both wild type and cotH mutant spores were then
tested for adsorption with increasing amounts of LTB.
Dot blot (Figure 5A) and densitometric analysis (Table 5)
of the obtained spots indicated that the amount of
spore-bound LTB increased when high amounts of puri-
fied LTB were used in the adsorption reaction. With wild
type spores about 1.5, 3.4 and 5.5 μg of LTB was displayed
after adsorption with 2.0, 10.0 or 20.0 μg of purified LTB,
respectively (Table 5). With cotH mutant spores, the effi-
ciency of adsorption is higher than with wild type spores
at all tested LTB concentrations and 1.8, 7.3 and 14.3 μg
of LTB were displayed on mutant spores using for the
Table 3 Densitometric analysis of dot blot experiments
with the supernatants of the adsorption reaction with
wild type and cotH mutant spores






Amount of LTB μg
in 200 μl (% total)
Purified LTB 12.50 ng 25.125 NA NA
6.25 ng 10.875 NA NA
3.12 ng 4.621 NA NA
wt 40 μl 16.517 9.2 0.04 (2.0)
20 μl 8.361 4.1 0.04 (2.1)
10 μl 4.383 1.9 0.03 (1.9)
cotH 80 μl 7.522 3.8 0.009 (0.4)
40 μl 2.987 1.2 0.006 (0.3)
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respectively (Table 5). Densitometric data of Table 5 are
summarized in Figure 5B and show that with wild type
spores (grey bars) the efficiency of LTB display decreased
from about 70% to 30% when high amounts of purified
LTB were used in the adsorption reaction. With cotH mu-
tant spores (black bars in Figure 5) the efficiency of LTB
only slightly decreased and remained around 70% when
10.0 and 20.0 μg of purified LTB were used in the adsorp-
tion reaction.
Spore-adsorbed LTB is in its active pentameric form
The heat-labile toxin of E. coli is similar to the cholera
toxin and is formed by an enzymatically active A subunit
and a pentameric non-toxic B subunit (LTB). Only in its
pentameric form LTB can bind its receptor, the ganglio-
side GM1, allowing entry of the A subunit into the host
eukaryotic cell. LTB alone is not toxic but able to induce
a potent mucosal immunogenic activity. In addition, LTB
can exert a mucosal adjuvant activity for coadministeredTable 4 Densitometric analysis of dot blot experiments
with the pellets of the adsorption reaction with wild type









Amount of LTB (μg/




25.0 ng 75.553 NA NA
12.5 ng 40.385 NA NA
6.25 ng 22.113 NA NA
wt 1 x 107 38.631 8.2 1.64 (82)
5 x 106 15.227 3.5 1.41 (70)
2.5 x 106 9.238 1.6 1.29 (65)
cotH 5 x 106 18.527 4.7 1.90 (95)
2.5 x 106 7.857 2.2 1.836 (91)
1.25 x 106 3.864 1.1 1.888 (94)unrelated antigens [24]. Although the mechanism of the ad-
juvant effects of LTB is not known, such activity strictly de-
pends on LTB ability to bind to its cell receptor GM1, and
therefore on the pentameric association of five B subunits
[24]. When LTB is expressed in a heterologous bacterium
fused to an anchor protein, pentamer formation is impaired
[25]. In order to assess whether LTB pentamers were
formed when LTB was displayed by the non-recombinant
system on the spore surface, an immunofluorescence mi-
croscopy analysis with anti-GM1 antibody was performed.
Wild type and cotH mutant spores of B. subtilis were
adsorbed with 10 μg of purified LTB as described above,
reacted with GM1 (Merck) and used for immunofluor-
escence analysis with anti-GM1 antibody. As shown in
Figure 6, spores of both strains were fluorescent indicat-
ing that GM1 was able to bind the spore surface and,
therefore, that LTB pentamers were present on the spore
surface. As expected for the high efficiency of LTB adsorp-
tion, cotH mutant spores were more fluorescent than the
wild type spores (Figure 6). When wild type or mutant
spores were adsorbed with LTB but not treated with GM1,
no fluorescence was observed after reaction with anti-
GM1 antibody (negative control in Figure 6), indicating the
specificity of the fluorescent signals observed when GM1
was used. The recombinant strain carrying a cotC::eltB
gene fusion and displaying the CotC-LTB fusion on the
spore surface [11] was also used for immunofluorescence
analysis with anti-GM1 antibody. As shown in Figure 6 no
fluorescence was observed around the recombinant spores,
indicating that no pentamers were present.
Conclusions
In this study we analyzed the adsorption of the B sub-
unit of the heat-labile toxin (LTB) of Escherichia coli to
spores of Bacillus subtilis. Although the recombinant
and non-recombinant display of antigens and enzymes on
B. subtilis spores has been reported previously [5,6,9,11-19],
our work highlights several new information that signifi-
cantly improve the potential applications of the spore-based
display system. First of all, the non-recombinant spore dis-
play approach based on surface absorption turned out to be
significantly more efficient than the recombinant approach,
the latter being based on the construction of gene fusions
between DNA coding for a spore coat protein (carrier) and
for LTB (passenger). An average of 9.6 × 10-5 pg of CotC-
LTB per spore was previously shown to be displayed by a
strain carrying a cotC::eltB gene fusion [11]. We report here
that using 20.0 μg of purified LTB in the adsorption reac-
tion, up to 2.5 × 10-3 pg of LTB per spore are displayed on
wild type spores. This about 25-fold increase of displayed
LTB becomes even larger by using mutant spores altered in
the spore surface. Indeed, with cotH null mutant spores, up
to 7.0 × 10-3 pg of LTB per spore were displayed, resulting
in a 2.5- and 70-fold increase with respect to wild type
Figure 5 Saturation of LTB adsorption. (A) The adsorption reactions were performed with 2.0 × 109 spores of the wild type and cotH mutant
strain and with 2.0, 10.0 and 20.0 μg of purified LTB. Serial dilutions of purified LTB were used as a standard. Wild type and mutant spores not
adsorbed with LTB were used as negative controls. Immuno-reactions were performed with anti-LTB antibody [10] and anti-rabbit secondary antibody
conjugated with the horseradish peroxidase. (B) Percentage of LTB bound to the spore surface of wild type (gray bars) or cotH mutant (black bars)
spores. The amount of LTB used in the adsorption reaction was considered as 100%. Error bars represent the standard deviation of each experiments.
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tant spores lacking CotH have been previously character-
ized [26,27]. In addition to CotH they lack at least nine
other coat proteins (CotH-dependent coat proteins) [28],
and as a consequence have strong defects in both inner and
outer coat [27]. These alterations reduce the total negative
charge of the spore [18] and we speculate that they could
also affect other physicochemical properties of the spore
relevant for adsorption. An increased efficiency of display is
particularly relevant when the system is aimed at delivering
an antigen to a mucosal surface, since it allows to reduce
the number of spores needed to induce an immune re-
sponse. Nine doses of 1.0 × 1010 recombinant spores induce
a specific immune response in mice [11]. However, scaling-
up that number to immunize humans would be extremely
difficult or even not realistic, making essential to develop
more efficient display systems.
A second main result of this work is that LTB forms
pentamers on the spore surface. Consistently with a pre-
vious report where LTB was displayed on the surface of
Streptococcus gordonii cells [25] also when expressed on
the spore surface as a fusion protein with CotC, LTBdoes not form pentamers (Figure 6). We show here that
the native, pentameric form of LTB was observed only
when purified LTB was adsorbed to spores. This aspect
is crucial since the immunostimulatory activity of LTB
largely depends on its ability to bind to its cell receptor,
most commonly the ganglioside GM1, which in turn re-
quires the association of B subunits to form a donut-
shaped pentamer via noncovalent associations. Pentamer
formation and interaction with the receptor result in en-
hanced targeting and access to MHC compartments [29]
with the consequent increased activation of antigen pre-
senting cells and T cells [30].
In conclusion, our work shows that by a non-
recombinant approach LTB can be efficiently displayed
in its native pentameric form on the spore surface and
that spore-displayed LTB molecules induce a Th1-biased
immune response in mice immunized by the nasal route.
These data, together with the well established robustness
and stability of the spore and the safety record of spores
of several species, propose the spore as a very promising
platform to display molecules to be presented to the hu-
man mucosal surfaces.
Table 5 Densitometric analysis of dot blot experiments
with the pellets of the adsorption reaction with wild type














25.0 ng 122.592 NA NA
12.5 ng 66.385 NA NA
6.25 ng 35.721 NA NA
2 μg
wt 1 × 107 36.331 7.2 1.50 (75)
5 × 106 22.387 3.8 1.52 (75)
2.5 × 106 14.418 1.2 1.45 (72)
cotH 5 × 106 30.527 4.2 1.92 (96)
2.5 × 106 19.157 2.3 1.86 (93)
1.25 × 106 9.564 1.3 1.79 (89)
10 μg
wt 1 × 107 98.331 19.7 3.94 (39)
5 × 106 51.387 8.7 3.48 (35)
2.5 × 106 28.418 3.6 2.88 (28)
cotH 1 × 107 142.37 32 6.4 (64)
5 × 106 97.285 19 7.6 (76)
2.5 × 106 53.644 10 8.0 (80)
20 μg
wt 5 × 106 66.778 12.8 5.1 (25)
25 × 106 42.422 7.5 6.0 (30)
cotH 5 × 106 159.87 35.2 14.3 (71)
2.5 × 106 87.56 17.34 13.8 (70)
1.25 × 106 42.422 9.83 15.0 (75)
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Bacterial strains and transformation
The B. subtilis PY79 strain [21] was used as a wild type.
Strain ER220 (cotH null mutant) [26] and all other mu-
tant strains of B. subtilis used in this study were isogenic
derivatives of PY79 and have all been described elsewhere
[18]. Isolation of plasmid DNA, restriction digestion, liga-
tion of DNA and transformation of E. coli competent cells
were carried out by standard methods [31].
Purification of spores and LTB
Sporulation of wild type and recombinant strains was in-
duced by the exhaustion method. After 30 h of growth
in Difco Sporulation medium (DSM) at 37°C with vigor-
ous shaking, spores were collected, washed three times
with distilled water and purified by renografin gradient
as described before [22]. Spore counts were determined
by serial dilution and plate-counting.
A recombinant plasmid containing the eltB gene, exclud-
ing the leader peptide coding sequence, of enterotoxigenicstrains of E. coli has been previously described [25]. A
DNA fragment of 321-bp was cleaved with KpnI and Hin-
dIII restriction enzymes and ligated into the expression
vector pRSETA (Invitrogen), previously digested with the
same enzymes. The recombinant plasmid carrying an in-
frame fusion of the 5’ end of the eltB coding region to six
histidine codons under the transcriptional control of a T7
promoter was used to transform competent cells of the E.
coli strain BL21(DE3) (Invitrogen), yielding strain RH153.
This strain was grown in ampicillin-supplemented (50 μg/
ml) LB medium to an optical density of 0.7 at 600 nm. The
T7 promoter was then induced by adding isopropyl-β D-
thiogalactoside (IPTG; final concentration, 0.5 mM) to the
culture, which was incubated for 4 h at 37°C [32]. The
six-His-tagged LTB protein was purified under native
conditions using the His-Trap column as recommended by
the manufacturer (GE Healthcare Life Science). Purified
protein was desalted using the PD10 column (GE Health-
care Life Science) to remove high NaCl and imidazole
concentrations.
Adsorption reaction
Purified LTB was added to a suspension of 2 × 109
spores in 0,15 M PBS pH 4.0 at 25°C in a final volume
of 200 μl. After 1 hour of incubation, the binding mix-
ture was centrifuged (10 min at 13,000 g) to fractionate
pellet and supernatant. The pellet was resuspended in
0,15 M PBS at pH 4.0 to a final concentration of 2 × 105
spores / μl and store at 4°C for further experiments.
Western and dot-blot analysis
2.0 × 108 spores adsorbed LTB were resuspended in 20 μl
of spore coat extraction buffer [22], incubated at 68°C for
1 hour to solubilize spore coat proteins and loaded onto a
12% SDS-PAGE gel. The proteins were then electrotrans-
ferred to nitrocellulose filters (Amersham Pharmacia Bio-
tech) and used for Western blot analysis as previously
reported [33].
A quantitative determination of the amount of LTB
was obtained by dot blot experiments with specific anti-
LTB antibodies analyzing serial dilutions of purified LTB,
binding assay supernatant and spore adsorbed LTB. Fil-
ters were then visualized by the ECL-prime (Amersham
Pharmacia Biotech) method and subjected to densito-
metric analysis by Fluor-S Multimager (Bio-Rad).
GM1 binding assay
2.0 × 109 spores were adsorbed with 10 μg LTB and an
aliquot of 2.0 × 106 reacted with 2 μg of Monosialotetra
hexosyl-ganglioside (GM1)(Merck) in 50 μl of 1×PBS,
pH 4.0 for 4 hours at 25°C. After three washes with PBS,
the samples were pretreated with 1% bovine serum albu-
min (BSA) - 1× PBS, pH 4.0 for 30 minutes prior to in-
cubation overnight a 4°C with the polyclonal anti-GM1
Figure 6 Immunofluorescence microscopy with anti-GM1 antibody. Wild type, cotH mutant and recombinant cotC::eltB spores were
adsorbed with 10.0 μg of LTB, treated with GM1 and reacted with anti-GM1 antibody and Texas Red conjugated secondary antibody. Spores
adsorbed with LTB but not treated with GM1 were also reacted with GM1 antibody (negative control). A representative microscopy field for each
strain is observed by phase contrast and immunofluorescence. Merged panels of phase contrast and immunofluorescence are shown. Exposure
times were typically in the range of 50–200 ms.
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BSA. As a control of the specificity of this technique,
both spores alone and spores adsorbed with LTB were
not reacted with GM1 and directly treated with anti-
GM1 antibodies. After three washes, the samples were
incubated with a 64-fold diluted anti-rabbit secondary
antibody conjugates with Tetramethyl Rhodamine, TRITC
(Santa Cruz Biotechnology, Inc.) and washed four times
with PBS. Washed samples were resuspended in 20 μl of
PBS and 10 μl analyzed using an immunofluorescence mi-
croscopy as previously described [34].
In vivo treatments
Female BALB/c mice were maintained in pathogen-free
conditions at the animal facility of the Institute of Food
Sciences and used at the age of 8–14 weeks. The studies
were approved by the National institutional review commit-
tee. Mice lightly anaesthetized with methoxuflurane were
intranasally administered once/week for 8 weeks with 2.0
μg of LTB or 2 × 109 LTB-adsorbed spores. Control mice
received only spores. Fecal pellets were collected at the end
of each week to monitor the induction of the LTB-specificimmunity. Mice were then sacrificed to collect, serum sam-
ples, spleens and mesenteric lymph nodes (MLN).Antibody analysis
Fecal pellets were homogenized in PBS + 0.01% sodium
azide (100 mg/ml) and centrifuged at 10,000 g 10 min;
supernatants were recovered and stored frozen or imme-
diately analysed.
Fecal anti-LTB IgA, serum anti-LTB IgA, IgG, IgG1
and IgG2a subclasses antibodies were assayed by ELISA.
LTB was coated onto U-bottomed microtiter plates at
1.0 μg/ well overnight at 4°C. Plates were blocked with
PBS containing 2% BSA. After washing with PBS contain-
ing 0.05% Tween-20 serial twofold dilutions of serum or
fecal supernatants were added to individual wells and in-
cubated for 2 hr at room temperature. The presence of
antibodies was detected with peroxidase-conjugated rabbit
anti-mouse IgA, IgG or isotype specific antibodies (Dako
SpA, Milan, Italy) and the reaction developed with 1 mg/
ml o-phenylendiamine/HCl substrate and 0.06% H2O2.
Results were expressed as absorbance values after blank
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tion exhibiting an O.D. ≥ 0.1 above negative controls.
Cytokine secretion assay
MLNs and spleens were passed through a stainless-steel
wire mesh to dissociate cells. Removal of erytrocytes
from spleen cells was performed by using a Tris-buffered
ammonium chloride solution. Cells were cultured at 2.5 ×
106 cells/ml in the presence/absence of LTB (10 μg/ml);
after 72 hr, the supernatants were collected and analyzed
for IFN-γ and IL-4 protein levels by ELISA using commer-
cial kits.
Statistical analysis
Differences among the various experimental groups were
determined by the Kruskal-Wallis non-parametric test, fol-
lowed by Dunn’s Multiple Comparison Test for post test
analysis.
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